Αποτελέσματα αναζήτησης - Kanwal Raghav

Περιορισμός αποτελεσμάτων
  1. 1
    Molecular Pathways and Mechanisms of HER2 in Cancer Therapy

    Molecular Pathways and Mechanisms of HER2 in Cancer Therapy από Kanwal Raghav, Mark M. Moasser

    Έκδοση 2022
    Λήψη πλήρους κειμένου
    Revisão
    Προσθήκη στα αγαπημένα
    Αποθηκεύτηκε σε:
  2. 2
    Small Bowel Adenocarcinoma: Etiology, Presentation, and Molecular Alterations

    Small Bowel Adenocarcinoma: Etiology, Presentation, and Molecular Alterations από Katrina S. Pedersen, Kanwal Raghav, Michael J. Overman

    Έκδοση 2019
    Λήψη πλήρους κειμένου Λήψη πλήρους κειμένου
    Revisão
    Προσθήκη στα αγαπημένα
    Αποθηκεύτηκε σε:
  3. 3
    Acquired Genomic Alterations on First-Line Chemotherapy With Cetuximab in Advanced Colorectal Cancer: Circulating Tumor DNA Analysis of the CALGB/SWOG-80405 Trial (Alliance)

    Acquired Genomic Alterations on First-Line Chemotherapy With Cetuximab in Advanced Colorectal Cancer: Circulating Tumor DNA Analysis of the CALGB/SWOG-80405 Trial (Alliance) από Kanwal Raghav, Fang‐Shu Ou, Alan P. Venook, Federico Innocenti, Ryan Sun, Heinz‐Josef Lenz, Scott Kopetz

    Έκδοση 2022
    Λήψη πλήρους κειμένου Λήψη πλήρους κειμένου
    Artigo
    Προσθήκη στα αγαπημένα
    Αποθηκεύτηκε σε:
  4. 4
    Representativeness of Black Patients in Cancer Clinical Trials Sponsored by the National Cancer Institute Compared With Pharmaceutical Companies

    Representativeness of Black Patients in Cancer Clinical Trials Sponsored by the National Cancer Institute Compared With Pharmaceutical Companies από Joseph M. Unger, Dawn L. Hershman, Raymond U. Osarogiagbon, Anirudh Gothwal, Seerat Anand, Arvind Dasari, Michael J. Overman, Jonathan M. Loree, Kanwal Raghav

    Έκδοση 2020
    Λήψη πλήρους κειμένου Λήψη πλήρους κειμένου
    Artigo
    Προσθήκη στα αγαπημένα
    Αποθηκεύτηκε σε:
  5. 5
    Advances in HER2-Targeted Therapy: Novel Agents and Opportunities Beyond Breast and Gastric Cancer

    Advances in HER2-Targeted Therapy: Novel Agents and Opportunities Beyond Breast and Gastric Cancer από Funda Meric‐Bernstam, Amber M. Johnson, Ecaterina E. Dumbrava, Kanwal Raghav, Kavitha Balaji, Michelle Bhatt, Rashmi K. Murthy, Jordi Rodón, Sarina A. Piha‐Paul

    Έκδοση 2018
    Λήψη πλήρους κειμένου
    Revisão
    Προσθήκη στα αγαπημένα
    Αποθηκεύτηκε σε:
  6. 6
    Plasma HER2 (<i>ERBB2</i>) Copy Number Predicts Response to HER2-targeted Therapy in Metastatic Colorectal Cancer

    Plasma HER2 (<i>ERBB2</i>) Copy Number Predicts Response to HER2-targeted Therapy in Metastatic Colorectal Cancer από Giulia Siravegna, Andrea Sartore‐Bianchi, Rebecca J. Nagy, Kanwal Raghav, Justin I. Odegaard, Richard B. Lanman, Livio Trusolino, Silvia Marsoni, Salvatore Siena, Alberto Bardelli

    Έκδοση 2019
    Λήψη πλήρους κειμένου Λήψη πλήρους κειμένου
    Artigo
    Προσθήκη στα αγαπημένα
    Αποθηκεύτηκε σε:
  7. 7
    Disparity of Race Reporting and Representation in Clinical Trials Leading to Cancer Drug Approvals From 2008 to 2018

    Disparity of Race Reporting and Representation in Clinical Trials Leading to Cancer Drug Approvals From 2008 to 2018 από Jonathan M. Loree, Seerat Anand, Arvind Dasari, Joseph M. Unger, Anirudh Gothwal, Lee M. Ellis, Gauri Varadhachary, Scott Kopetz, Michael J. Overman, Kanwal Raghav

    Έκδοση 2019
    Λήψη πλήρους κειμένου Λήψη πλήρους κειμένου
    Artigo
    Προσθήκη στα αγαπημένα
    Αποθηκεύτηκε σε:
  8. 8
    Bevacizumab combined with capecitabine and oxaliplatin in patients with advanced adenocarcinoma of the small bowel or ampulla of vater: A single‐center, open‐label, phase 2 study

    Bevacizumab combined with capecitabine and oxaliplatin in patients with advanced adenocarcinoma of the small bowel or ampulla of vater: A single‐center, open‐label, phase 2 study... από Pat Gulhati, Kanwal Raghav, Rachna T. Shroff, Gauri R. Varadhachary, Scott Kopetz, Milind Javle, Wei Qiao, Huamin Wang, Jeffrey S. Morris, Robert A. Wolff, Michael J. Overman

    Έκδοση 2016
    Λήψη πλήρους κειμένου
    Artigo
    Προσθήκη στα αγαπημένα
    Αποθηκεύτηκε σε:
  9. 9
    cMET and Phospho-cMET Protein Levels in Breast Cancers and Survival Outcomes

    cMET and Phospho-cMET Protein Levels in Breast Cancers and Survival Outcomes από Kanwal Raghav, Wenting Wang, Shuying Liu, Mariana Chávez‐MacGregor, Xiaolong Meng, Gabriel N. Hortobágyi, Gordon B. Mills, Funda Meric‐Bernstam, George R. Blumenschein, Ana M. González-Angulo

    Έκδοση 2012
    Λήψη πλήρους κειμένου Λήψη πλήρους κειμένου
    Artigo
    Προσθήκη στα αγαπημένα
    Αποθηκεύτηκε σε:
  10. 10
    International Harmonization of Provisional Diagnostic Criteria for <i>ERBB2</i>-Amplified Metastatic Colorectal Cancer Allowing for Screening by Next-Generation Sequencing Panel

    International Harmonization of Provisional Diagnostic Criteria for <i>ERBB2</i>-Amplified Metastatic Colorectal Cancer Allowing for Screening by Next-Generation Sequencing Panel από Satoshi Fujii, Anthony M. Magliocco, Jihun Kim, Wataru Okamoto, Jeong Eun Kim, Kentaro Sawada, Yoshiaki Nakamura, Scott Kopetz, Woong‐Yang Park, Katsuya Tsuchihara, Tae Won Kim, Kanwal Raghav, Takayuki Yoshino

    Έκδοση 2020
    Λήψη πλήρους κειμένου Λήψη πλήρους κειμένου
    Artigo
    Προσθήκη στα αγαπημένα
    Αποθηκεύτηκε σε:
  11. 11
    Impact of low estrogen/progesterone receptor expression on survival outcomes in breast cancers previously classified as triple negative breast cancers

    Impact of low estrogen/progesterone receptor expression on survival outcomes in breast cancers previously classified as triple negative breast cancers από Kanwal Raghav, Leonel F. Hernandez‐Aya, Xiudong Lei, Mariana Chávez‐MacGregor, Funda Meric‐Bernstam, Thomas A. Buchholz, Ayşegül A. Şahin, Kors Jan A., Gabriel N. Hortobágyi, Ana M. González-Angulo

    Έκδοση 2011
    Λήψη πλήρους κειμένου
    Artigo
    Προσθήκη στα αγαπημένα
    Αποθηκεύτηκε σε:
  12. 12
    Impact of Molecular Alterations and Targeted Therapy in Appendiceal Adenocarcinomas

    Impact of Molecular Alterations and Targeted Therapy in Appendiceal Adenocarcinomas από Kanwal Raghav, Aditya Shetty, Syed Mohammad Ali Kazmi, Nianxiang Zhang, Jeffrey S. Morris, Melissa W. Taggart, Keith F. Fournier, Richard E. Royal, Paul Mansfield, Cathy Eng, Robert A. Wolff, Michael J. Overman

    Έκδοση 2013
    Λήψη πλήρους κειμένου
    Artigo
    Προσθήκη στα αγαπημένα
    Αποθηκεύτηκε σε:
  13. 13
    Local therapy reduces the risk of liver failure and improves survival in patients with intrahepatic cholangiocarcinoma: A comprehensive analysis of 362 consecutive patients

    Local therapy reduces the risk of liver failure and improves survival in patients with intrahepatic cholangiocarcinoma: A comprehensive analysis of 362 consecutive patients από Suguru Yamashita, Eugene J. Koay, Guillaume Passot, Rachna T. Shroff, Kanwal Raghav, Claudius Conrad, Yun Shin Chun, Thomas A. Aloia, Randa Tao, Ahmed O. Kaseb, Milind Javle, Christopher H. Crane, Jean‐Nicolas Vauthey

    Έκδοση 2016
    Λήψη πλήρους κειμένου Λήψη πλήρους κειμένου
    Artigo
    Προσθήκη στα αγαπημένα
    Αποθηκεύτηκε σε:
  14. 14
    The Addition of Bevacizumab to Oxaliplatin-Based Chemotherapy: Impact Upon Hepatic Sinusoidal Injury and Thrombocytopenia

    The Addition of Bevacizumab to Oxaliplatin-Based Chemotherapy: Impact Upon Hepatic Sinusoidal Injury and Thrombocytopenia από Michael J. Overman, Renata Ferrarotto, Kanwal Raghav, Binsah George, Wei Qiao, Karime Kalil Machado, Leonard B. Saltz, Thibault Mazard, Jean‐Nicolas Vauthey, Paulo M. Hoff, Brian P. Hobbs, Evelyn Loyer, Scott Kopetz

    Έκδοση 2017
    Λήψη πλήρους κειμένου Λήψη πλήρους κειμένου
    Artigo
    Προσθήκη στα αγαπημένα
    Αποθηκεύτηκε σε:
  15. 15
    Integrated clinico-molecular profiling of appendiceal adenocarcinoma reveals a unique grade-driven entity distinct from colorectal cancer

    Integrated clinico-molecular profiling of appendiceal adenocarcinoma reveals a unique grade-driven entity distinct from colorectal cancer από Kanwal Raghav, John Paul Shen, Alexandre A. Jácome, Jennifer L. Guerra, Christopher P. Scally, Melissa W. Taggart, Wai Chin Foo, Aurelio Matamoros, Kenna Shaw, Keith F. Fournier, Michael J. Overman, Cathy Eng

    Έκδοση 2020
    Λήψη πλήρους κειμένου Λήψη πλήρους κειμένου
    Artigo
    Προσθήκη στα αγαπημένα
    Αποθηκεύτηκε σε:
  16. 16
    Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers

    Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers από Rachna T. Shroff, Milind Javle, Lianchun Xiao, Ahmed O. Kaseb, Gauri R. Varadhachary, Robert A. Wolff, Kanwal Raghav, Michiko Iwasaki, Peter Masci, Ramesh K. Ramanathan, Daniel H. Ahn, Tanios Bekaii‐Saab, Mitesh J. Borad

    Έκδοση 2019
    Λήψη πλήρους κειμένου Λήψη πλήρους κειμένου
    Artigo
    Προσθήκη στα αγαπημένα
    Αποθηκεύτηκε σε:
  17. 17
    <i>FBXW7</i> missense mutation: a novel negative prognostic factor in metastatic colorectal adenocarcinoma

    <i>FBXW7</i> missense mutation: a novel negative prognostic factor in metastatic colorectal adenocarcinoma από Krittiya Korphaisarn, Van K. Morris, Michael J. Overman, David R. Fogelman, Bryan K. Kee, Kanwal Raghav, Shanequa Manuel, Imad Shureiqi, Robert A. Wolff, Cathy Eng, David G. Menter, Stanley R. Hamilton, Scott Kopetz, Arvind Dasari

    Έκδοση 2017
    Λήψη πλήρους κειμένου Λήψη πλήρους κειμένου
    Artigo
    Προσθήκη στα αγαπημένα
    Αποθηκεύτηκε σε:
  18. 18
    Phase I trial of the combination of the pan-ErbB inhibitor neratinib and mTOR inhibitor everolimus in advanced cancer patients with family gene alterations

    Phase I trial of the combination of the pan-ErbB inhibitor neratinib and mTOR inhibitor everolimus in advanced cancer patients with family gene alterations από Sarina A. Piha‐Paul, Chieh Tseng, Hai T. Tran, Aung Naing, Ecaterina E. Dumbrava, DD Karp, Jordi Rodón, Timothy A. Yap, Kanwal Raghav, Senthil Damodaran, Xiao‐Feng Le, P.T. Soliman, Jo Ann Lim, F. Meric-Bernstam

    Έκδοση 2025
    Λήψη πλήρους κειμένου
    Artigo
    Προσθήκη στα αγαπημένα
    Αποθηκεύτηκε σε:
  19. 19
    Overall Survival in Phase 3 Clinical Trials and the Surveillance, Epidemiology, and End Results Database in Patients With Metastatic Colorectal Cancer, 1986-2016: A Systematic Review

    Overall Survival in Phase 3 Clinical Trials and the Surveillance, Epidemiology, and End Results Database in Patients With Metastatic Colorectal Cancer, 1986-2016: A Systematic Revi... από Shen, Chan, Tannenbaum, Daniel, Horn, Robert, Rogers, Jane, Eng, Cathy, Zhou, Shouhao, Johnson, Benny, Kopetz, Scott, Morris, Van, Overman, Michael, Parseghian, Christine, Chang, George J., Lopez-Olivo, Maria A., Kanwal, Raghav, Ellis, Lee M., Dasari, Arvind

    Έκδοση 2022
    Λήψη πλήρους κειμένου Λήψη πλήρους κειμένου Λήψη πλήρους κειμένου
    Κείμενο
    Προσθήκη στα αγαπημένα
    Αποθηκεύτηκε σε:
  20. 20
    Phase II study of nab-paclitaxel in refractory small bowel adenocarcinoma and CpG island methylator phenotype (CIMP)-high colorectal cancer

    Phase II study of nab-paclitaxel in refractory small bowel adenocarcinoma and CpG island methylator phenotype (CIMP)-high colorectal cancer από Michael J. Overman, L. Adam, Kanwal Raghav, J. Wang, Bryan K. Kee, David R. Fogelman, Cathy Eng, Eduardo Vilar, Rachna T. Shroff, Arvind Dasari, Robert A. Wolff, Jeffrey S. Morris, Enusha Karunasena, Thomas R. Pisanic, Nilofer S. Azad, Scott Kopetz

    Έκδοση 2017
    Λήψη πλήρους κειμένου Λήψη πλήρους κειμένου
    Artigo
    Προσθήκη στα αγαπημένα
    Αποθηκεύτηκε σε:

Εργαλεία αναζήτησης: